Medtronic, Inc. announced that a judge in the Eastern District Court of Virginia last week ruled in Medtronic’s favor in a patent case brought by W.L Gore & Associates, Inc., based in Newark, Del.
The patent in question involved a method of making stent grafts, which are implantable medical devices used to treat aortic aneurysms. The judge determined that Medtronic’s stent grafts did not infringe on Gore’s U.S. Patent No. 5,810,870.
Gore’s medical business is headquartered in Arizona. Gore has its headquarters and a large cluster of operations around its Newark headquarters, primarily in Cecil County, Md.
“We’re pleased with the court’s decision,” said Tony Semedo, vice president and general manager for the Endovascular Therapies at Medtronic, “which enables us to continue our focus on advancing the standard of care for the endovascular repair of aortic aneurysms. In that context, respect for intellectual property remains a core principle that we continuously and vigorously defend. “
